Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AWATAR: Antithrombotic Therapy Strategies Post-TAVR in Severe Aortic Regurgitation
NCT07677410Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jul 2026
- Primary completion
- Jul 2029
- Countries
- 1
01
Overview
Randomised trial of aspirin in aortic regurgitation (AR) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Non-hierarchical Composite Endpoint at 12 months. Started Jul 2026; status: recruiting.
02
Drugs
aspirin
03
Conditions
aortic regurgitation (AR)
Beyond the preview
Go deeper on NCT07677410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07677410.